ARTICLE | Company News
Kosan other research news
July 3, 2000 7:00 AM UTC
Kosan received a $500,000 Phase I SBIR grant from the National Institute of Allergy and Infectious Diseases to develop analogs of Fujisawa Healthcare Inc.'s Prograf tacrolimus FK506 with increased r...